Bicycle Therapeutics plc

Direct answer

Bicycle Therapeutics plc is publicly traded on NASDAQ under the ticker BCYC.

Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently lacking effective treatments. The company's leading investigational product, BT1718, is a Bicycle Toxin Conjugate (BTC) that is undergoing Phase I/IIa clinical trials. This candidate is engineered to target tumors...

Can you invest in Bicycle Therapeutics plc?

Yes. Bicycle Therapeutics plc is publicly traded on NASDAQ under the ticker BCYC.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Bicycle Therapeutics plc

Detailed equity research is provided by MarketSnap.